Mead Johnson Nutrition Co. (NYSE:MJN) was down 2.5% during trading on Thursday . The stock traded as low as $82.73 and last traded at $82.98, with a volume of 864,795 shares changing hands. The stock had previously closed at $85.07.

Several equities research analysts have recently commented on MJN shares. Credit Suisse Group AG reissued a “buy” rating and issued a $96.00 price objective on shares of Mead Johnson Nutrition in a report on Thursday, June 30th. Susquehanna reissued a “hold” rating on shares of Mead Johnson Nutrition in a report on Monday, August 8th. Societe Generale downgraded Mead Johnson Nutrition from a “buy” rating to a “hold” rating and cut their price objective for the company from $100.00 to $95.00 in a report on Friday, July 29th. JPMorgan Chase & Co. reissued an “overweight” rating and issued a $105.00 price objective on shares of Mead Johnson Nutrition in a report on Friday, August 5th. Finally, BMO Capital Markets reissued an “outperform” rating and issued a $97.00 price objective on shares of Mead Johnson Nutrition in a report on Monday, August 1st. One research analyst has rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the company’s stock. Mead Johnson Nutrition presently has a consensus rating of “Hold” and a consensus target price of $96.00.

The company has a market cap of $15.39 billion and a P/E ratio of 31.35. The stock has a 50 day moving average of $88.23 and a 200-day moving average of $84.21.

Mead Johnson Nutrition (NYSE:MJN) last announced its earnings results on Thursday, July 28th. The company reported $0.88 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.10. The company had revenue of $941.50 million for the quarter, compared to analysts’ expectations of $967.25 million. The firm’s quarterly revenue was down 8.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.76 EPS. On average, equities research analysts anticipate that Mead Johnson Nutrition Co. will post $3.52 earnings per share for the current year.

In related news, SVP Graciela Monteagudo sold 45,873 shares of Mead Johnson Nutrition stock in a transaction that occurred on Friday, August 5th. The stock was sold at an average price of $87.64, for a total transaction of $4,020,309.72. Following the transaction, the senior vice president now owns 13,800 shares of the company’s stock, valued at $1,209,432. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Kimberly A. Casiano sold 710 shares of Mead Johnson Nutrition stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $89.75, for a total value of $63,722.50. Following the transaction, the director now directly owns 7,110 shares in the company, valued at approximately $638,122.50. The disclosure for this sale can be found here.

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.